KIRAMBU CHOORNAM IN SEIZURES

Pre clinical and clinical evaluation of the effect on oral administration of "KIRAMBU CHOORANAM" along with "VARMA THERAPY " in the management of "VALIPPU NOI IN PEDIATRIC AGE GROUP"

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040797

Enrollment

Registered

2022-03-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G409- Epilepsy, unspecified

Interventions

Intervention1: Kirambu chooranam: Should be orally twice a day after food for a period 12 days dose- 2gm Control Intervention1: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patient with seizure or history of seizure Patient who had taken anti psychiatric drugs Patient with febrile fits Seizure due to cerebral palsy, hypoxic ischaemic encephalopathy

Exclusion criteria

Exclusion criteria: Children above 12 years Non epileptic seizure events ( pseudoseizures) Toxic ingestion Seizure due to SOL Seizure due to trauma Status epilepticus Brain tumour

Design outcomes

Primary

Measure	Time frame
Reduction in clinical symptomsTimepoint: Reduction in clinical symptoms with in 12 days	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr D K Soundararajan MD s

Government siddha medical college and hospital

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026